Ovid Therapeutics Inc.

OVID

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001636651

SEC filings (opens in a new tab)

No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Ovid Therapeutics Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of OVID: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Of which not filed for Q3 2025	Q3 2025	Change
Holders	71	1	81	+11
Shares	36.0M	17.0K	36.2M	+263.0K (+0.7%)
Value	$11.9M	$5.61K	$47.1M	+$35.2M (+297.1%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Ovid Therapeutics Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to OVID in Q3 2025
Institution	Shares	Value	% of portfolio
Ikarian Capital, LLC	1,095,574	$1.42M	0.32%
Schonfeld Strategic Advisors LLC	883,154	$1.15M	0.01%
Balyasny Asset Management LLC	625,000	$812.5K	0.00%
Walleye Capital LLC	596,717	$775.7K	0.01%
Boothbay Fund Management, LLC	486,877	$632.9K	0.02%
Citadel Advisors LLC	405,382	$527.0K	0.00%
Simplex Trading, LLC	387,512	$503.0K	0.01%
Two Sigma Investments, LP	341,134	$443.5K	0.00%
Parkman Healthcare Partners LLC	202,978	$263.9K	0.03%
Group One Trading, L.P.	188,295	$244.8K	0.01%
Diadema Partners LP	187,739	$244.1K	0.17%
Two Sigma Advisers, LP	151,800	$197.3K	0.00%
Integrated Wealth Concepts LLC	52,900	$68.8K	0.00%
Persistent Asset Partners Ltd	46,040	$59.9K	0.04%
Quadrature Capital Ltd	27,703	$35.9K	0.00%
Apollon Wealth Management, LLC	27,500	$35.8K	0.00%
Private Advisor Group, LLC	25,600	$33.3K	0.00%
Cetera Investment Advisers	17,000	$22.1K	0.00%
LPL Financial LLC	12,000	$15.6K	0.00%
Two Sigma Securities, LLC	11,698	$15.2K	0.00%
Quadcap Wealth Management, LLC	11,111	$14.4K	0.00%
Sovereign Financial Group, Inc.	10,000	$13.0K	0.00%
North Star Investment Management Corp.	1,043	$1.36K	0.00%
Advisory Services Network, LLC	219	$285	0.00%
SRS Capital Advisors, Inc.	140	$182	0.00%

Sold out (14)

Institutions that held Ovid Therapeutics Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of OVID in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
BVF Inc	3,853,818	$1.27M
Madison Avenue Partners, LP	1,311,362	$432.6K
Rosalind Advisors, Inc.	500,000	$164.9K
Rubric Capital Management LP	478,533	$157.9K
Y-Intercept (Hong Kong) Ltd	160,306	$52.9K
HRT Financial LP	123,316	$40.0K
HSBC Holdings PLC	19,220	$6.01K
Newman Dignan & Sheerar, Inc.	16,522	$5.45K
AQR Capital Management LLC	15,705	$5.18K
PFG Investments, LLC	13,975	$4.61K
Jump Financial, LLC	13,718	$4.53K
Virtu Financial LLC	12,664	$4.00K
EverSource Wealth Advisors, LLC	24	$8
True Wealth Design, LLC	8	$3

Not filed for Q3 2025 yet (1)

Institutions that held Ovid Therapeutics Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OVID in Q2 2025 that haven't filed for Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Avantax Advisory Services, Inc.	17,000	$5.61K